Full-Year 2012 Targets
($ billions, except per-share amounts)
Adjusted Income/Diluted EPS(1) Targets
~$18.3 - $19.1
~$2.25 - $2.35
Purchase Accounting Impacts of Transactions Completed as of 7/4/10
Reported Net Income Attributable to Pfizer Inc./Diluted EPS Targets
(a) The current exchange rates assumed in connection with the 2012 financial targets are the mid-July 2010 exchange rates.
(b)Given the longer-term nature of these targets, they are subject to greater variability and less certainty as a result of potential material impacts related to foreign exchange fluctuations, macroeconomic activity including inflation, and industry-specific challenges including changes to government healthcare policy, among others.
Subscribe to our Free Newsletters!